Goat Milk Formula
Dietary SupplementInfants will receive goat milk-based formula as their primary feeding during the intervention period, according to standard feeding practices.
NCT Number: NCT07778927
Infant gastrointestinal discomfort is common in early life and can affect feeding, sleep, and overall well-being. Goat milk formula, due to its unique protein composition and smaller fat globules, may be easier to digest and potentially improve gastrointestinal tolerance in infants.
This study is a multicenter, randomized, controlled trial designed to evaluate the effects of goat milk formula compared with standard cow milk formula in infants aged 0-5 months with gastrointestinal discomfort. The study will assess improvements in gastrointestinal symptoms, overall comfort, behavioral status, and early growth and development, as well as explore potential changes in gut microbiota and intestinal inflammation.
Trial opening soon.
Get NotifiedUp to 5 month
All sexes
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Infants will receive goat milk-based formula as their primary feeding during the intervention period, according to standard feeding practices.
Infants will receive standard cow milk-based formula as their primary feeding during the intervention period, according to routine feeding practices.
Time frame: Baseline to Day 14
The overall response rate is defined as the proportion of participants in each group showing a ≥30% improvement in ICCS from baseline to Day 14. ICCS is a composite measure combining gastrointestinal symptom burden and behavioral state, with total scores ranging from 0 to 30. Higher scores indicate better overall comfort (better outcome). Response is categorized as: Markedly Effective (improvement ≥50%), Effective (improvement ≥30% to <50%), and Ineffective (improvement <30% or worsening). The overall response rate is calculated as (Markedly Effective + Effective) / Total Cases × 100%.
Time frame: Baseline to Day 28
Change in gastrointestinal symptom burden score from baseline to Day 28, assessed using the Infant Gastrointestinal Symptom Assessment Scale. The scale ranges from 0 to 15, with higher scores indicating greater symptom burden (worse outcome).
Time frame: Day 28
Proportion of infants with complete resolution of individual gastrointestinal symptoms (e.g., abdominal distension, crying, vomiting) by Day 28.
Time frame: Baseline to Day 28
Change in total daily sleep duration (minutes) based on caregiver-recorded 24-hour infant behavior diary.
Time frame: Baseline to Day 28
Change in total daily duration of awake and content state as reported by caregivers.
Time frame: Baseline to Day 28
Change from baseline to Day 28 in parent-reported infant comfort experience, assessed using the following instrument:
Parenting Feeding and Nurturing Experience Questionnaire total score. This questionnaire consists of 5 items, each scored from 1 to 5, giving a total score range of 5 to 25. Higher scores indicate a more positive parenting and feeding experience (better outcome).
Time frame: Baseline to Day 28
Change from baseline to Day 28 in parent-reported infant feeding experience, assessed using the following instrument:
Visual Analogue Scale (VAS) scores for parent-perceived infant overall comfort, feeding smoothness, and maternal anxiety. Each VAS item ranges from 0 to 10. For all three items, higher scores indicate better outcomes (i.e., more comfort, smoother feeding, and less anxiety).
Time frame: Baseline to Day 28
Change in weight-for-age Z-score from baseline to Day 28. Weight is measured in kilograms (kg) using a calibrated electronic infant scale. The Z-score is a continuous variable (standard deviation units relative to the WHO child growth standard), with a typical clinical range of -3 to +3. Higher Z-scores indicate greater weight for age, generally reflecting better growth outcomes in this population.
Time frame: Baseline to Day 28
Change in head circumference-for-age Z-score from baseline to Day 28. Head circumference is measured in centimeters (cm) using a non-stretchable measuring tape. The Z-score is a continuous variable (standard deviation units relative to the WHO child growth standard), with a typical clinical range of -3 to +3. Higher Z-scores indicate greater head circumference for age, reflecting appropriate brain and cranial growth.
Time frame: Baseline to Day 28
Change in length-for-age Z-score from baseline to Day 28. Length is measured in centimeters (cm) using a standard infant length measurement board. The Z-score is a continuous variable (standard deviation units relative to the WHO child growth standard), with a typical clinical range of -3 to +3. Higher Z-scores indicate greater length for age, generally reflecting better growth outcomes in this population.
Time frame: Baseline and Week 4
Changes in gut microbiota composition, including relative abundance of key bacterial taxa, assessed by 16S rRNA sequencing of stool samples.
Time frame: Baseline and Week 4
Change in fecal calprotectin concentration as a marker of intestinal inflammation.
Contact information is provided by the study sponsor or research team.
Ruijin Hospital
Other
A Multicenter, Randomized, Controlled Trial to Evaluate the Effects of Goat Milk Formula on Gastrointestinal Comfort, Behavioral Status, and Early Growth and Development in Infants
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07222943
Abdominal Pain, Abdominal Pain/ Discomfort
Austin, Texas, United States
View Trial DetailsNCT07320287
Body Weight, Body Weight Changes
Hanoi, Vietnam
View Trial DetailsNCT07000227
Colonic Diseases, Colonic Diseases, Functional
Kuala Lumpur, Malaysia
View Trial DetailsNCT06863207
Autonomic Nervous System Diseases, Cyclic Vomiting Syndrome
Milwaukee, Wisconsin, United States
View Trial Details